ACHILLES THERAPEUTICS PLC's ticker is ACHL and the CUSIP is 00449L102. A total of 26 filers reported holding ACHILLES THERAPEUTICS PLC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $66,577 | +594.7% | 73,242 | +622.2% | 0.00% | – |
| Q2 2023 | $9,584 | -34.5% | 10,142 | -33.7% | 0.00% | – |
| Q1 2023 | $14,637 | +52.4% | 15,295 | +43.3% | 0.00% | – |
| Q4 2022 | $9,603 | -54.3% | 10,670 | +11.7% | 0.00% | – |
| Q3 2022 | $21,000 | -32.3% | 9,556 | -22.4% | 0.00% | – |
| Q2 2022 | $31,000 | 0.0% | 12,319 | +17.9% | 0.00% | – |
| Q1 2022 | $31,000 | +34.8% | 10,450 | +130.8% | 0.00% | – |
| Q4 2021 | $23,000 | +27.8% | 4,528 | +91.3% | 0.00% | – |
| Q3 2021 | $18,000 | -94.3% | 2,367 | -92.7% | 0.00% | – |
| Q2 2021 | $316,000 | -96.7% | 32,346 | -94.4% | 0.00% | -100.0% |
| Q1 2021 | $9,535,000 | – | 576,085 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Syncona Portfolio Ltd | 11,086,909 | $10,087,979 | 15.03% |
| Artal Group S.A. | 2,255,375 | $2,052 | 0.09% |
| Redmile Group, LLC | 1,608,089 | $1,463,200 | 0.07% |
| Forefront Analytics, LLC | 78,169 | $71,126 | 0.04% |
| Baker Brothers Advisors | 2,557,149 | $2,326,750 | 0.01% |
| Point72 Asset Management, L.P. | 1,413,809 | $1,286,425 | 0.00% |
| XTX Topco Ltd | 21,084 | $19,184 | 0.00% |
| Coppell Advisory Solutions LLC | 1,000 | $5,560 | 0.00% |
| Renaissance Technologies | 437,528 | $398 | 0.00% |
| JPMORGAN CHASE & CO | 989 | $900 | 0.00% |